- Home
- ZIM vs CLDX Comparison
ZIM vs CLDX Comparison
Compare ZIM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZIM | CLDX |
|---|---|---|
| Founded | 1945 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ZIM | CLDX |
|---|---|---|
| Price | $28.20 | $40.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | $19.26 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 1.9M | 933.3K |
| Earning Date | 05-20-2026 | 05-04-2026 |
| Dividend Yield | ★ 7.65% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | N/A | $111.39 |
| Revenue Next Year | N/A | $235.85 |
| P/E Ratio | $3.49 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $12.33 | $21.34 |
| 52 Week High | $29.97 | $45.14 |
Technical Indicators
Market Signals| Indicator | ZIM | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 60.08 | 54.46 |
| Support Level | $27.61 | $28.51 |
| Resistance Level | $29.07 | $45.14 |
| Average True Range (ATR) | 1.00 | 1.75 |
| MACD | 0.18 | -0.30 |
| Stochastic Oscillator | 72.63 | 42.37 |
Price Performance
Historical ComparisonAbout ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.